Nuvation Bio Inc.
NUVB
$2.23
-$0.13-5.51%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -606.38M | -567.94M | -532.28M | -510.72M | -68.87M |
| Total Depreciation and Amortization | 935.00K | 683.00K | 519.00K | 412.00K | 224.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 453.25M | 449.35M | 439.82M | 436.44M | 8.04M |
| Change in Net Operating Assets | -5.14M | -12.51M | -7.20M | -10.35M | -3.77M |
| Cash from Operations | -157.34M | -130.41M | -99.14M | -84.21M | -64.37M |
| Capital Expenditure | -207.00K | -162.00K | -188.00K | -62.00K | -84.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 14.00K | 14.00K | 14.00K |
| Cash Acquisitions | 12.43M | 12.43M | 12.52M | 12.52M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 157.12M | 110.44M | 91.75M | 52.91M | 68.53M |
| Cash from Investing | 169.34M | 122.70M | 104.09M | 65.39M | 68.46M |
| Total Debt Issued | 12.61M | 12.61M | 7.04M | 7.04M | -- |
| Total Debt Repaid | -17.70M | -17.16M | -9.53M | -6.32M | -- |
| Issuance of Common Stock | 5.95M | 4.89M | 3.85M | 2.25M | 351.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 858.00K | 331.00K | 1.35M | 2.97M | 351.00K |
| Foreign Exchange rate Adjustments | 604.00K | 453.00K | -664.00K | 78.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.47M | -6.93M | 5.64M | -15.78M | 4.44M |